QED have been established for almost 20 years. They are based in San Diego, California and have a wide focus, but are very strong in Infectious Disease and Cancer Research.
Eileen Skaletsky the President and CEO,
“We have been creating and manufacturing antibodies for almost 20 years. We are the original manufacturer of most of the antibodies we offer, and this gives us the advantage of knowing complete development histories and manufacturing processes which can be very useful information to our customers. This also gives us the ability to provide our antibodies in virtually any quantity that customers want with substantial discounts for bulk orders.”
A recent success story has been the introduction of a monoclonal antibody to Human Rhinovirus (HRV) that instantly became very popular. HRV infections are characteristic upper airway infections (the main cause of the common cold), and they provoke significant lower airway symptoms for patients with asthma, cystic fibrosis, or chronic obstructive pulmonary disease.